Post-licensure vaccine services

AI Summary

The Vaccine Development and Evaluation Centre (VDEC), a core component of the UK Health Security Agency (UKHSA) based at Porton Down, provides specialized support for vaccine and therapeutic development. As this document is a services overview rather than an audit report, it does not list specific inspection dates or violations; however, it outlines the stringent regulatory framework under which VDEC operates, specifically Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP). The facility assists partners in industry, academia, and government through every stage of development, with a particular focus on the post-licensure phase to ensure ongoing product safety and efficacy. Key service offerings include supporting the annual UK influenza vaccine batch release, conducting immunogenicity and antisera studies for Phase IV clinical trials, and providing molecular surveillance. Additionally, VDEC performs batch release testing for licensed vaccines, develops potency tests for developmental products, and conducts stability studies. By maintaining these high-standard laboratory services, VDEC plays a critical role in the regulatory pipeline. Organizations seeking to leverage these capabilities for vaccine evaluation and release are encouraged to contact the UKHSA to initiate collaboration and ensure their products meet necessary safety and quality benchmarks.